Eli Lilly Announces Pricing for Mounjaro in India

Eli Lilly has announced the pricing for its diabetes treatment Mounjaro in India. The 2.5 mg vial of Mounjaro is priced at 3,500 rupees, while the 5 mg vial is priced at 4,375 rupees. This pricing strategy aims to make the medication more accessible to patients in India, where diabetes management is a significant healthcare concern. Mounjaro, known for its effectiveness in managing blood sugar levels, is part of Lilly's efforts to expand its presence in the Indian pharmaceutical market.

Source: Reuters, Eli Lilly and Company